Parametric response mapping of dynamic CT as an imaging biomarker to distinguish viability of hepatocellular carcinoma treated with transcatheter arterial chemoembolization

被引:11
作者
Choi, Seung Joon [1 ]
Kim, Jonghoon [2 ]
Seo, Jongbum [3 ]
Kim, Hyung Sik [1 ]
Lee, Jong-min [4 ]
Park, Hyunjin [2 ]
机构
[1] Gachon Univ, Gil Hosp, Dept Radiol, Inchon, South Korea
[2] Sungkyunkwan Univ, Sch Elect & Elect Engn, Suwon, South Korea
[3] Yonsei Univ, Dept Biomed Engn, Wonju, South Korea
[4] Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea
来源
ABDOMINAL IMAGING | 2014年 / 39卷 / 03期
基金
新加坡国家研究基金会;
关键词
Hepatocellular carcinoma; Parametric response mapping; Automatic classifier; Transcatheter arterial chemoembolization; Dynamic CT; Longitudinal exam; TRANSARTERIAL CHEMOEMBOLIZATION; LIPIODOL-CHEMOEMBOLIZATION; EMBOLIZATION; THERAPY; MAP; LIVER; RECURRENCES; COMBINATION; MANAGEMENT; SORAFENIB;
D O I
10.1007/s00261-014-0087-z
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Accurate assessment of viability of hepatocellular carcinoma (HCC) after transcatheter arterial chemoembolization (TACE) is important for therapy planning. The purpose of this study is to determine the diagnostic value of a novel image analysis method called parametric response mapping (PRM) in predicting viability of tumor in HCC treated with TACE for dynamic CT images. 35 patients who had 35 iodized-oil defect areas (IODAs) in HCCs treated with TACE were included in our study. These patients were divided into two groups, one group with viable tumors (n = 22) and the other group with non-viable tumors (n = 13) in the IODA. All patients were followed up using triple-phase dynamic CT after the treatment. We compared (a) manual analysis, (b) using PRM results, and (c) using PRM results with automatic classifier to distinguish between two tumor groups based on dynamic CT images from two longitudinal exams. Two radiologists performed the manual analysis. The PRM approach was implemented using prototype software. We adopted an off-the-shelf k nearest neighbor (kNN) classifier and leave-one-out cross-validation for the third approach. The area under the curve (AUC) values were compared for three approaches. Manual analysis yielded AUC of 0.74, using PRM results yielded AUC of 0.84, and using PRM results with an automatic classifier yielded AUC of 0.87. We improved upon the standard manual analysis approach by adopting a novel image analysis method of PRM combined with an automatic classifier.
引用
收藏
页码:518 / 525
页数:8
相关论文
共 50 条
[11]   Complete response with sorafenib and transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma [J].
Michitoshi Takano ;
Takashi Kokudo ;
Yoshihiro Miyazaki ;
Yumiko Kageyama ;
Amane Takahashi ;
Katsumi Amikura ;
Hirohiko Sakamoto .
World Journal of Gastroenterology, 2016, (42) :9445-9450
[12]   Evaluating the therapeutic effect of hepatocellular carcinoma treated with transcatheter arterial chemoembolization by magnetic resonance perfusion imaging [J].
Chen, Xiangyu ;
Xiao, Enhua ;
Shu, Dianshuang ;
Yang, Chengzhi ;
Liang, Bin ;
He, Zhong ;
Bian, Dujun .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 26 (01) :109-113
[13]   Parametric response mapping of contrast-enhanced biphasic CT for evaluating tumour viability of hepatocellular carcinoma after TACE [J].
Hinrichs, Jan B. ;
Shin, Hoen-Oh ;
Kaercher, Daniel ;
Hasdemir, Davut ;
Murray, Tim ;
Kaireit, Till ;
Lutat, Carolin ;
Vogel, Arndt ;
Meyer, Bernhard C. ;
Wacker, Frank K. ;
Rodt, Thomas .
EUROPEAN RADIOLOGY, 2016, 26 (10) :3447-3455
[14]   Sarcopenia as a prognostic factor in patients with hepatocellular carcinoma treated with transcatheter arterial chemoembolization plus sorafenib [J].
Wang, Rujian ;
Wang, Ligang ;
Jiang, Yutian ;
Dong, Mei ;
Li, Mei ;
Sun, Ping .
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2024, 20 (04) :1208-1213
[15]   Hepatocellular carcinoma associated with budd-chiari syndrome: imaging features and transcatheter arterial chemoembolization [J].
Liu, Feng-Yong ;
Wang, Mao-Qiang ;
Duan, Feng ;
Fan, Qing-Sheng ;
Song, Peng ;
Wang, Yan .
BMC GASTROENTEROLOGY, 2013, 13
[16]   Delayed enhancement of hepatocellular carcinoma on dynamic CT: sign of extrahepatic collaterals after transcatheter arterial chemoembolization or transcatheter arterial chemoinfusion [J].
Katoh, T ;
Mitani, M ;
Noma, K ;
Sunayama, T ;
Nakano, S ;
Toyama, Y ;
Ohkawa, M .
ABDOMINAL IMAGING, 2002, 27 (01) :34-39
[17]   Novel imaging biomarkers of response to transcatheter arterial chemoembolization in hepatocellular carcinoma patients [J].
Favelier, Sylvain ;
Estivalet, Louis ;
Pottecher, Pierre ;
Loffroy, Romaric .
CHINESE JOURNAL OF CANCER RESEARCH, 2015, 27 (06) :611-616
[18]   Influencing factors related to transcatheter arterial chemoembolization for hepatocellular carcinoma patients achieved tumor response [J].
Shao, Hongyan ;
Deng, Juan ;
Xie, Luping ;
Zheng, Qiwen ;
Zou, Bihui ;
Deng, Jun ;
Zhang, Tianqi ;
He, Jingjing .
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2022, 18 (02) :560-566
[19]   Prognostic factors of hepatocellular carcinoma patients with portal vein tumor thrombosis treated with transcatheter arterial chemoembolization [J].
Liang, Hongyuan ;
Cui, Peng ;
Guo, Qiyong ;
Mao, Xiaonan ;
Wen, Feng ;
Sun, Wei ;
Shan, Ming ;
Lu, Zaiming .
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 (05) :E331-E341
[20]   Prediction of Therapeutic Response of Hepatocellular Carcinoma to Transcatheter Arterial Chemoembolization Based on Pretherapeutic Dynamic CT and Textural Findings [J].
Park, Hyun Jeong ;
Kim, Jung Hoon ;
Choi, Seo-youn ;
Lee, Eun Sun ;
Park, Sang Joon ;
Byun, Jae Young ;
Choi, Byung Ihn .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2017, 209 (04) :W211-W220